phenyl acetate has been researched along with ursodeoxycholic acid in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 3 (60.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bacon, BR; Bernstein, DE; Boudes, PF; Bowlus, CL; Buggisch, P; Chera, H; Choi, YJ; Clark, V; Corless, L; Doerffel, Y; Freilich, BL; Galambos, MR; Gitlin, N; Gordon, SC; Hartleb, M; Hartmann, H; Hirschfield, GM; Janczewska, E; Jonas, ME; Jones, D; Kremer, AE; Levy, C; Martin, R; McWherter, CA; Mells, GF; Odin, JA; Rochling, F; Shah, H; Sheridan, D; Shiffman, ML; Smith, JH; Steinberg, A; Swain, MG; Varga, M; Vierling, JM; Wörns, MA | 1 |
| Mothersill, C; Rollo, D; Seymour, C; Vo, NTK; Vukmirovic, D | 1 |
| Aspinall, RJ; Berg, CP; Boudes, P; Bowlus, CL; Choi, YJ; Dörffel, Y; Galambos, MR; Goel, A; Gordon, SC; Harrison, SA; Hirschfield, GM; Jones, DEJ; Kremer, AE; Levy, C; Mayo, MJ; McWherter, CA; Neff, GW; Sheridan, DA; Shiffman, ML; Stanca, CM; Steinberg, A; Swain, MG; Thuluvath, PJ; Vierling, JM | 1 |
| Mishra, AK; Singh, SP | 1 |
| Andreone, P; Aspinall, RJ; Boudes, PF; Bowlus, CL; Choi, YJ; Corpechot, C; Dalekos, GN; Drenth, JPH; Fassio, E; Forman, L; Gonzalez-Huezo, MS; Gordon, SC; Gulamhusein, A; Heneghan, MA; Hinrichsen, H; Hirschfield, GM; Invernizzi, P; Janczewska, E; Jeong, SH; Jones, DEJ; Kowdley, KV; Kremer, AE; Ladrón de Guevara, AL; Lawitz, EJ; Leggett, BA; Levy, C; Mayo, MJ; McWherter, CA; Nevens, F; Pratt, DS; Raikhelson, K; Ryder, SD; Shiffman, ML; Steinberg, A; Swain, MG; Trivedi, PJ; Vargas, V; Vierling, JM; Zigmond, E; Zuckerman, E | 1 |
3 trial(s) available for phenyl acetate and ursodeoxycholic acid
| Article | Year |
|---|---|
Seladelpar (MBX-8025), a selective PPAR-δ agonist, in patients with primary biliary cholangitis with an inadequate response to ursodeoxycholic acid: a double-blind, randomised, placebo-controlled, phase 2, proof-of-concept study.
Topics: Acetates; Adult; Aged; Alanine Transaminase; Cholangitis; Diarrhea; Double-Blind Method; Drug Administration Schedule; Female; Humans; Liver; Male; Middle Aged; Nausea; PPAR delta; Pruritus; Treatment Outcome; Triazoles; Ursodeoxycholic Acid | 2017 |
A phase II, randomized, open-label, 52-week study of seladelpar in patients with primary biliary cholangitis.
Topics: Acetates; Adult; Alkaline Phosphatase; Disease Progression; Humans; Liver Cirrhosis, Biliary; Pruritus; Ursodeoxycholic Acid | 2022 |
Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study.
Topics: Acetates; Alkaline Phosphatase; Cholagogues and Choleretics; Humans; Liver Cirrhosis, Biliary; Pruritus; Ursodeoxycholic Acid | 2023 |
2 other study(ies) available for phenyl acetate and ursodeoxycholic acid
| Article | Year |
|---|---|
Characterization of Radioprotective, Radiomitigative and Bystander Signaling Modulating Effects of Endogenous Metabolites - Phenylacetate, Ursodeoxycholate and Tauroursodeoxycholate - on HCT116 Human Colon Carcinoma Cell Line.
Topics: Acetates; Bystander Effect; Cell Survival; Colonic Neoplasms; Dose-Response Relationship, Radiation; HCT116 Cells; Humans; Phenols; Radiation-Protective Agents; Signal Transduction; Taurochenodeoxycholic Acid; Ursodeoxycholic Acid | 2019 |
Seladelpar in patients with primary biliary cholangitis: Need for a closer look!
Topics: Acetates; Cholagogues and Choleretics; Cholangitis; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid | 2022 |